Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Neogen (NEOG) over the last 15 years, with Q4 2025 value amounting to -$867000.0.

  • Neogen's Exchange Rate Effect rose 5514.74% to -$867000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $2.2 million, marking a year-over-year increase of 20317.97%. This contributed to the annual value of $942000.0 for FY2025, which is 28764.94% up from last year.
  • According to the latest figures from Q4 2025, Neogen's Exchange Rate Effect is -$867000.0, which was up 5514.74% from $694000.0 recorded in Q3 2025.
  • Neogen's Exchange Rate Effect's 5-year high stood at $5.8 million during Q3 2022, with a 5-year trough of -$13.7 million in Q4 2022.
  • For the 5-year period, Neogen's Exchange Rate Effect averaged around -$689550.0, with its median value being -$527500.0 (2022).
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first plummeted by 2751428.57% in 2024, then soared by 892903.23% in 2025.
  • Neogen's Exchange Rate Effect (Quarter) stood at -$4.2 million in 2021, then crashed by 221.86% to -$13.7 million in 2022, then soared by 99.95% to -$7000.0 in 2023, then tumbled by 27514.29% to -$1.9 million in 2024, then skyrocketed by 55.15% to -$867000.0 in 2025.
  • Its Exchange Rate Effect stands at -$867000.0 for Q4 2025, versus $694000.0 for Q3 2025 and $2.8 million for Q2 2025.